anmelden
NASDAQ 100
29.064,90
PKT
-255,76
PKT
-0,87
%
Indikation*
29.064,80
PKT
-255,86
PKT
-0,87
%
Offiziell
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NASDAQ 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.05.12 | Kraft Heinz Company halten | Hamburger Sparkasse AG (Haspa) | |
| 21.05.12 | Walmart overweight | Barclays Capital | |
| 21.05.12 | Intuit overweight | Barclays Capital | |
| 21.05.12 | Intuit kaufen | Die Actien-Börse | |
| 21.05.12 | Applied Materials outperform | RBC Capital Markets | |
| 21.05.12 | Ross Stores sector perform | RBC Capital Markets | |
| 21.05.12 | Dollar Tree outperform | RBC Capital Markets | |
| 21.05.12 | Autodesk sector perform | RBC Capital Markets | |
| 18.05.12 | Applied Materials buy | Stifel, Nicolaus & Co., Inc. | |
| 18.05.12 | Walmart neutral | Sarasin Research | |
| 18.05.12 | Walmart kaufen | National-Bank AG | |
| 18.05.12 | CSX overweight | Barclays Capital | |
| 17.05.12 | Cisco overweight | Barclays Capital | |
| 16.05.12 | Baker Hughes outperform | RBC Capital Markets | |
| 16.05.12 | Apple overweight | Barclays Capital | |
| 15.05.12 | Applied Materials hold | Needham & Company, LLC | |
| 15.05.12 | NVIDIA equal-weight | Barclays Capital | |
| 14.05.12 | Xcel Energy outperform | Robert W. Baird & Co. Incorporated | |
| 14.05.12 | Cisco kaufen | Independent Research GmbH | |
| 11.05.12 | Charter A outperform | Barrington Research | |
| 11.05.12 | Apple overweight | Morgan Stanley | |
| 11.05.12 | Cisco equal-weight | Barclays Capital | |
| 11.05.12 | Intel buy | UBS AG | |
| 11.05.12 | Tesla overweight | Barclays Capital | |
| 11.05.12 | Booking overweight | Barclays Capital | |
| 11.05.12 | Amazon halten | Der Aktionär | |
| 11.05.12 | Monster Beverage buy | UBS AG | |
| 11.05.12 | Monster Beverage buy | Stifel, Nicolaus & Co., Inc. | |
| 10.05.12 | Cisco buy | UBS AG | |
| 10.05.12 | Cisco buy | Stifel, Nicolaus & Co., Inc. | |
| 10.05.12 | Cisco outperform | Oppenheimer & Co. Inc. | |
| 10.05.12 | Regeneron Pharmaceuticals outperform | RBC Capital Markets | |
| 10.05.12 | Intel outperform | RBC Capital Markets | |
| 10.05.12 | Cisco neutral | Sarasin Research | |
| 10.05.12 | Biogen buy | UBS AG | |
| 09.05.12 | Analog Devices neutral | UBS AG | |
| 09.05.12 | Apple overweight | Barclays Capital | |
| 09.05.12 | Vertex Pharmaceuticals overweight | Barclays Capital | |
| 09.05.12 | Cognizant overweight | Barclays Capital | |
| 08.05.12 | Vertex Pharmaceuticals buy | Needham & Company, LLC |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.